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Abstract
Background—Because of health disparities, incarcerated persons are at higher risk for multiple 
health issues, including HIV. Correctional facilities have an opportunity to provide HIV services 
to an underserved population. This article describes Centers for Disease Control and Prevention 
(CDC)–funded HIV testing and service delivery in correctional facilities.
Methods—Data on HIV testing and service delivery were submitted to CDC by 61 health 
department jurisdictions in 2013. HIV testing, HIV positivity, receipt of test results, linkage, and 
referral services were described, and differences across demographic characteristics for linkage 
and referral services were assessed. Finally, trends were examined for HIV testing, HIV positivity, 
and linkage from 2009 to 2013.
Results—Of CDC-funded tests in 2013 among persons 18 years and older, 254,719 (7.9%) were 
conducted in correctional facilities. HIV positivity was 0.9%, and HIV positivity for newly 
diagnosed persons was 0.3%. Blacks accounted for the highest percentage of HIV-infected 
persons (1.3%) and newly diagnosed persons (0.5%). Only 37.9% of newly diagnosed persons 
were linked within 90 days; 67.5% were linked within any time frame; 49.7% were referred to 
partner services; and 45.2% were referred to HIV prevention services. There was a significant 
percent increase in HIV testing, overall HIV positivity, and linkage from 2009 to 2013. However, 
trends were stable for newly diagnosed persons.
Conclusions—Identification of newly diagnosed persons in correctional facilities has remained 
stable from 2009 to 2013. Correctional facilities seem to be reaching blacks, likely due to higher 
incarceration rates. The current findings indicate that improvements are needed in HIV testing 
strategies, service delivery during incarceration, and linkage to care postrelease.
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At the end of 2013, more than 1.5 million persons were incarcerated in state and federal 
prisons in the United States, and 731,200 were held in jails.1 Incarcerated persons are often 
disproportionately affected by multiple health issues, including HIV and other sexually 
transmitted diseases (STDs).2 According to the Bureau of Justice Statistics, the rate of HIV/
AIDS among incarcerated persons has declined from 194 per 10,000 in 2001 to 146 per 
10,000 in 2010. However, at the end of 2010, 20,093 incarcerated persons were living with 
HIV/AIDS.3 Data on Centers for Disease Control and Prevention (CDC)–funded testing in 
2006 indicated 0.9% HIV positivity in correctional facilities and 0.7% newly diagnosed 
HIV-infected persons (new positives).4 Men aged 25 to 34 years, blacks, Hispanics/Latinos, 
persons tested in the South, men who have sex with men, and persons who inject drugs are 
more likely to be HIV infected or new positives.4–6 New positives in correctional facilities 
also have reported riskier behavior, including sex with someone other than their main 
partner, unsafe vaginal/anal sex, and sex with an at-risk partner (i.e., injected drugs, HIV-
infected, or men who have sex with men).5,7
In addition to disproportionate incarceration rates, minority populations are 
disproportionately affected by HIV/AIDS. Blacks accounted for 44% of new infections in 
2010 and 41.0% of persons living with HIV in 2011.8,9 Among CDC-funded HIV testing in 
2013, 54.9% of all new positives were blacks.10 Moreover, Hispanic/Latinos accounted for 
21.0% of new infections in 2010 and 20.0% of persons living with HIV in 2011.8,9 
Correctional facilities are an important setting to provide HIV testing and service delivery 
for underserved, vulnerable populations who may be at risk for HIV/STDs.2,11
The CDC recommends routine HIV screening in health care settings for persons aged 13 to 
64 years, where prevalence is 0.1% or greater.12 The CDC for HIV testing in correctional 
medical clinics has recommended that testing be performed unless the person declines (opt-
out screening).13 Some implementation challenges with testing in correctional facilities 
include privacy, rapid release from jail, lack of resources, feasibility, and costs.2,14 Recent 
evidence suggests that opt-out testing and rapid HIV testing are feasible methods to identify 
persons unaware of their HIV status because results are delivered within 20 minutes. These 
methods may be beneficial in facilities with short lengths of stay and allow for early 
initiation of HIV treatment.2,5–7,14
However, challenges remain along the continuum of care for HIV-infected persons. A recent 
systematic review found low rates of HIV awareness, linkage and retention in care, and viral 
suppression among incarcerated populations.15 Most incarcerated persons spend time in jails 
only,16 and turnover and short-release times can frequently disrupt HIV care.17 Because 
there is a 40% probability of recidivism, jails can help with continuity of care through 
effective transitional programs for HIV-infected persons.15,16,18
HIV testing in correctional facilities provides an opportunity to target a population at high 
risk for HIV infection who may not otherwise access health care services. HIV service 
provision would not only benefit incarcerated persons but also their sexual and drug-using 
networks.4,11 Therefore, a better understanding of HIV testing, HIV positivity, and service 
delivery in correctional facilities is necessary. This article describes CDC-funded HIV 
testing and HIV-related services in correctional facilities in 2013. The aims are to assess (1) 
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HIV testing; (2) identification of HIV-infected persons, including new positives; (3) linkage 
to HIV medical care; (4) referral to partner services; and (5) referral to HIV prevention 
services. Demographic characteristics of persons who received HIV-related services in 
correctional facilities were described. In addition, differences across demographic 
characteristics on linkage and referral services were analyzed, and trends for HIV testing, 




Since 2012, the CDC has funded 61 health department jurisdictions, which include the 50 
states, District of Columbia, Puerto Rico, US Virgin Islands, and 8 directly funded city/
county health departments to provide HIV testing and other HIV prevention activities. 
Previously, from 2009 to 2011, 59 health departments were funded. HIV testing data are 
collected locally and submitted biannually to the National HIV Prevention Program 
Monitoring and Evaluation (NHM&E) system, a secure CDC-supported online reporting 
system. Data submitted by June 2, 2014, from CDC-funded nonclinical and clinical 
correctional facilities, were included for 2013 analyses. A nonclinical correctional facility is 
defined as a penal or correctional facility, prison, jail detention center, community-based 
rehabilitation center, or any similar institution designed for the confinement or rehabilitation 
of criminal offenders. A clinical correctional facility is defined as an area within a penal or 
correctional facility, including prison and adult or juvenile detention facilities, that provides 
medical or health services.
Measures
Demographics—This included self-reported data on age, sex, and race/ethnicity. 
Jurisdictions were assigned to the Northeast, South, Midwest, and West, using US Census 
categorizations.
HIV Testing Events and Receipt of HIV Test Results—HIV testing events included 
all HIV testing records submitted to the NHM&E system, for which a test technology 
(conventional, rapid, nucleic acid amplification test, RNA viral load testing, or other) or test 
result (positive, negative, indeterminate, or invalid) was reported. Data on test technology 
were categorized as rapid test only, conventional test only (nucleic acid amplification 
test/RNA or other conventional HIV test), or rapid and conventional. Receipt of HIV test 
result measured whether persons received results from the initial testing site or obtained 
results from another agency for at least one test in the testing event.
HIV Positivity—HIV-infected persons included those who tested HIV-positive during the 
current test event. New positives included those who tested HIV positive during the current 
test event but self-reported not having a previous HIV-positive test result.
Linkage to HIV Medical Care—Linkage was defined as attendance at first medical 
appointment for HIV-infected persons. Grantees collect these data in various ways, 
Seth et al. Page 3













including client self-report, medical records, surveil-lance, or local program data. Linkage 
was examined for new positives in 2013. Trend analyses from 2009 to 2013 examined 
linkage for both HIV-infected persons and new positives. In addition, linkage within 90 days 
and linkage within any time frame (i.e., within 90 days and >90 days) are described.
Referral for Partner Services—Partner services are a set of confidential, voluntary 
services to help HIV-infected persons notify their sex and drug injection partners of possible 
HIV exposure, to offer services that can protect the health of partners, and to prevent STD 
reinfection.19 Persons who were either referred to or interviewed for partner services were 
considered referred. Referral for partner services was examined for new positives in 2013.
Referral to HIV Prevention Services—HIV prevention services are defined as any 
service or intervention directly aimed at reducing risk for transmitting or acquiring HIV 
infection (e.g. risk-reduction counseling).20 It excludes HIV posttest counseling and indirect 
services such as mental health services or housing. Referral to HIV prevention services was 
examined for new positives in 2013.
Data Analysis Plan
Descriptive statistics examined HIV testing and service delivery in correctional facilities by 
demographic characteristics. In addition, log binominal analyses assessed differences across 
demographic characteristics for linkage and referral services. Finally, estimated annual 
percent change (EAPC) analyses examined trends in HIV testing and service delivery in 
correctional facilities from 2009 to 2013. Analyses were conducted in SAS, version 9.3.
RESULTS
HIV Testing and Receipt of HIV Test Results
In 2013, 3,213,187 CDC-funded HIV testing events were conducted among persons 18 years 
and older. Of those, 254,719 (7.9%) were conducted in correctional facilities. Puerto Rico 
and the US Virgin Islands did not submit data from correctional facilities in 2013; therefore, 
results are from 59 health department jurisdictions. Most HIV testing events in correctional 
facilities were conducted among persons aged 18 to 29 years (44.2%) and 30 to 39 years 
(26.5%), males (75.8%), and in the South (46.7%) and Northeast (34.0%). By race/ethnicity, 
45.8% of HIV testing events were among blacks, compared with 29.6% among whites and 
18.9% among Hispanics/Latinos. Rapid HIV testing was the most commonly used HIV test 
technology, accounting for 69.6% of testing events (Table 1).
HIV test results were provided for 76.3% of all CDC-funded testing events in correctional 
facilities. Descriptive analyses revealed that 77.9% of persons aged 40 to 49 years, 77.0% of 
persons 50 years and older, 78.5% of males, 82.2% of blacks, 98.2% of persons in the 
Midwest, and 81.0% of persons in the South received their results. Only 64.7% of Hispanic/
Latina females received their results, which was relatively lower than other racial/ethnic and 
sex groups (Table 1).
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HIV positivity was 0.9% (2289) in correctional facilities. Persons aged 40 to 49 years 
(1.6%) and 50 years and older (2.0%), blacks (1.3%), and persons in the South (1.5%) were 
the groups with the highest percentages of HIV-infected persons. Among all HIV testing 
events, 0.3% (841) were new positives, and among all HIV-infected persons, 36.7% 
(841/2289) were new positives. Descriptive analyses revealed that 0.5% of persons aged 40 
to 49 years, 0.6% of persons 50 years and older, 0.5% of blacks, and 0.5% of persons in the 
South were new positives. By race/ethnicity, 0.5% of blacks, 0.2% of Hispanics/Latinos, and 
0.2% of whites were new positives (Table 1).
Linkage to HIV Medical Care and Referral Services
Among the 841 new positives, 67.5% were linked to HIV medical care within any time 
frame after testing. Descriptive analyses revealed that 72.3% of persons 50 years and older, 
67.9% of males, and 72.3% of persons in the Northeast were linked within any time frame. 
Log binomial regression analyses indicated that whites (59.1%) were linked within any time 
frame significantly less than blacks (69.6%). In addition, persons in the Midwest (32.1%) 
were linked within any time frame significantly less than persons in the South (67.5%; Table 
2).
Among all new positives, 37.9% were linked to HIV medical care within 90 days. 
Descriptive analyses revealed that 43.8% of persons aged 18 to 29 years, 38.2% of males, 
42.2% of blacks, and 66.7% of persons in the West were linked within 90 days. Log 
binomial regression analyses indicated that persons 50 years and older (33.1%) were linked 
within 90 days significantly less than persons aged 18 to 29 years (43.8%). In addition, 
whites (24.7%) were linked within 90 days significantly less than blacks (42.2%). Finally, 
white males (23.5%) and Hispanic/Latino males (28.3%) were linked within 90 days 
significantly less than black males (43.8%), and Hispanic/Latina females (70.0%) were 
linked within 90 days significantly more than black females (35.0%; Table 2).
Approximately half of new positives were referred to partner services. Descriptive analyses 
revealed that 70.0% of Hispanic/ Latina females and 53.8% of white females were referred 
to partner services, whereas only 39.1% of Hispanic/Latino males and 38.3% of white males 
were referred. Log binomial regression analyses indicated that persons aged 30 to 39 years 
(47.2%), 40 to 49 years of age (41.2%), and 50 years and older (44.6%) were referred to 
partner services significantly less than persons aged 18 to 29 years (60.2%). Also, Hispanic/
Latino males (39.1%) and white males (38.3%) were referred to partner services 
significantly less than black males (52.4%). Hispanic/Latina females (70.0%) were referred 
to partner services significantly more than black females (44.0%). Finally, persons in the 
Northeast (27.0%) were referred to partner services significantly less than persons in the 
South (53.1%), whereas those in the West (78.9%) were referred significantly more than 
those in the South (Table 2).
Finally, 45.2% of new positives were referred to HIV prevention services. Descriptive 
analyses indicated that 51.5% of persons aged 18 to 29 years, 45.5% of males, and 48.7% of 
whites were referred to HIV prevention services. Log binomial regression analyses indicated 
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that persons aged 30 to 39 years (40.6%) and 50 years and older (39.9%) were referred to 
HIV prevention services significantly less than persons aged 18 to 29 years (51.5%). Also, 
persons in the Northeast (72.3%) and in the West (70.2%) were referred to HIV prevention 
services significantly more than persons in the South (35.8%; Table 2).
HIV Testing and HIV Positivity From 2009 to 2013
Trend analyses indicated that the number of HIV testing events in correctional facilities 
increased from 2009 to 2012 and decreased slightly in 2013. The EAPC increase for the 
number of HIV testing events between 2009 and 2013 was 2.7% (Fig. 1). The percentage of 
HIV-infected persons and new positives varied between years. From 2009 to 2013, the 
EAPC for total HIV positivity increased by 4.4% (P < 0.001). Although not statistically 
significant, the EAPC for new positives between 2009 and 2013 decreased by 2.1% (P > 
0.05). Overall, identification of new positives remained stable at 0.3% from 2010 to 2013 
(Fig. 2).
The EAPC of HIV-infected persons linked to HIV medical care within any time frame 
increased from 2009 to 2010, decreased in 2011, and increased in 2012 and in 2013. The 
percentage of HIV-infected persons linked significantly increased by 26.8% (P < 0.001) 
between 2009 and 2013. The percentage of new positives linked to HIV medical care within 
any time frame increased from 2009 to 2010 but decreased in 2011, resulting in a fairly 
stable percentage of persons linked between the 3 years. However, the linkage percentages 
increased considerably in 2012 and in 2013. The EAPC of new positives linked significantly 
increased by 15.6% (P < 0.001) between 2009 and 2013 (Fig. 3).
DISCUSSION
HIV testing and knowledge of HIV status are gateways to services along the HIV continuum 
of care. Early initiation of and adherence to antiretroviral therapy has substantial medical 
and prevention benefits for HIV-infected persons by reducing HIV transmission to HIV-
negative partners by up to 96%.21,22 Therefore, it is critical to ensure all HIV-infected 
persons receive necessary HIV prevention, care, and treatment services. The National HIV/
AIDS Strategy23 has set goals of reducing new HIV infections and having 85% of new 
positives linked to HIV medical care within 90 days by 2015. In 2013, only 37.9% of new 
positives in correctional facilities were linked to medical care within 90 days, and 67.5% 
were linked within any time frame. Percentages for referral to partner services and HIV 
prevention services also were relatively low at 49.7% and 45.2%, respectively. Linkage and 
referral percentages should be significantly improved to ensure that HIV-infected persons 
and their partners have access to HIV prevention and treatment services.
Overall, blacks accounted for 45.8%, and black males accounted for 37.0% of the CDC-
funded HIV testing events conducted in correctional facilities. In addition, overall HIV 
positivity among blacks was highest compared with other racial/ethnic groups. The 
percentage of new positives also was highest among blacks at 0.5%, although lower than the 
1.0% found in a previous study on CDC-funded testing in correctional facilities.4 These 
findings are consistent with blacks being disproportionately affected by HIV in the United 
States.9,10
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HIV testing events funded by CDC in correctional facilities increased overall from 2009 to 
2012 but decreased in 2013. Although overall HIV positivity increased from 2009 to 2013, 
the percentage of new positives has remained stable at 0.3% since 2010. This suggests that 
despite the overall increase in HIV testing, it has become more challenging to identify new 
positives. For example, a previous study on CDC-funded testing in 2006 found 0.7% new 
positives.4 In addition, in comparison to several other CDC-funded site types in 2013, 
correctional facilities identified a lower percentage of new positives.24
The findings have limitations. Type of correctional facility is not a required reporting 
variable by CDC. Jails have a rapid turnover, whereas prisons have longer incarceration 
times so testing and HIV-related service delivery may occur more frequently. Because of 
challenges with ensuring linkage and continuation of services for persons postrelease, data 
on services provided post-release were likely not reported, leading to missing data. 
Moreover, the percentage of missing data was high across service delivery indicators. 
Therefore, results are likely underestimating service delivery and represent the minimum 
percent achieved. Linkage to HIV medical care within 90 days became a required reporting 
variable starting in 2012. This may contribute to incomplete data because of the time it may 
take grantees to update their data systems for reporting. However, there have been 
significant improvements in data quality each year. In addition, self-report was used to 
identify new positives. The percentage of new positives is likely an overestimate because of 
self-report bias and because HIV testing programs often offer incentives for getting tested. 
Finally, although the sample size is large, this article only represents CDC-funded tests in 
correctional facilities. Therefore, findings may not be generalizable to all correctional 
facilities in the United States.
Centers for Disease Control and Prevention guidance recommends that HIV testing in 
correctional facilities be offered both upon entry and before release as part of routine 
care.2,13 However, because of varying policies and limited resources, implementation varies 
by state, county, and facility.25 A recent study found that only 19% of prisons and 35% of 
jails provide opt-out testing. In addition, less than 20% followed CDC's recommendations 
regarding discharge planning services.26 To reduce new HIV infections, it is important to 
test and treat, as indicated, populations at high risk for HIV. In 2006, an estimated 14% of 
HIV-infected persons had contact with a correctional facility.16 This provides an opportunity 
to link underserved HIV-infected persons into HIV medical care and other prevention 
services before they return to their communities and sexual and drug-using networks. 
However, previous research suggests that it is challenging to retain HIV-infected persons 
who receive services while incarcerated in HIV care and other prevention services 
postrelease.15,27,28 They may not adhere to their HIV medications, discontinue treatment, 
and/or engage in high risk behavior that may increase HIV transmission.27,28 Other factors 
that may contribute are poor access to health care upon release, substance use, mental health 
issues, unstable housing, and unemployment.11,13,27,29–31
Routine HIV testing and provision of HIV-related services in correctional facilities have 
important public health implications. Efforts should be made to increase opt-out testing and 
improve the continuum of care postrelease.15 Transitional programs beyond case 
management could facilitate HIV medical care and other prevention services postrelease. 
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Collaboration between prisons and community-based organizations may ensure continuation 
of services.13,32 Incarcerated persons with HIV are a vulnerable and underserved population. 
Providing HIV-related services will not only benefit their health but also the health of the 
communities to which they return. Various cost-effective and feasible program-matic 
models that consider the unique policy and economic factors of HIV testing and provision of 
HIV-related services in correctional facilities and postrelease should be evaluated.
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Number of CDC-funded HIV testing events in correctional facilities in the United States, 
2009–2013.
Seth et al. Page 10














Percentages of HIV-infected and newly diagnosed HIV-infected persons in correctional 
facilities in the United States, 2009–2013.
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Percentages of HIV-infected and newly diagnosed HIV-infected persons linked to HIV 
medical care within any time frame in correctional facilities in the United States, 2009–
2013.
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